Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer
Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer
Not yet recruiting · NCT07102940 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 2 | 2026-06-11 | NCT07102940 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| George Washington University | 62 |
| Immutep S.A.S. | 4 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||